Page last updated: 2024-08-21

rhein and Cardiomyopathies

rhein has been researched along with Cardiomyopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Al-Hasani, H; Barbosa, DM; Fahlbusch, P; Hartwig, S; Herzfeld de Wiza, D; Jacob, S; Kettel, U; Knebel, B; Kotzka, J; Krüger, M; Lehr, S; Ouwens, DM	1

Other Studies

1 other study(ies) available for rhein and Cardiomyopathies

Article	Year
Rhein, a novel Histone Deacetylase (HDAC) inhibitor with antifibrotic potency in human myocardial fibrosis. Scientific reports, 2020, 03-17, Volume: 10, Issue:1 Topics: Adult; Anthraquinones; Blotting, Western; Cardiomyopathies; Cyclin-Dependent Kinase Inhibitor p21; Female; Fibroblasts; Histone Deacetylase 1; Histone Deacetylase 2; Humans; Male; Middle Aged; Real-Time Polymerase Chain Reaction; Smad2 Protein; Smad3 Protein; Smad7 Protein; Transcriptome; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases	2020

Article

Year

Rhein, a novel Histone Deacetylase (HDAC) inhibitor with antifibrotic potency in human myocardial fibrosis.

Scientific reports, 2020, 03-17, Volume: 10, Issue:1

Topics: Adult; Anthraquinones; Blotting, Western; Cardiomyopathies; Cyclin-Dependent Kinase Inhibitor p21; Female; Fibroblasts; Histone Deacetylase 1; Histone Deacetylase 2; Humans; Male; Middle Aged; Real-Time Polymerase Chain Reaction; Smad2 Protein; Smad3 Protein; Smad7 Protein; Transcriptome; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases

2020